Published in J Infect Dis on February 01, 1980
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00
Production of enterotoxin by Yersinia enterocolitica. Infect Immun (1978) 3.94
Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med (1993) 3.67
5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med (1972) 3.55
Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med (1986) 3.43
Campylobacter gastroenteritis in children. J Pediatr (1979) 3.42
Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics (1994) 3.38
Serum resistance associated with virulence in Yersinia enterocolitica. Infect Immun (1982) 3.37
Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J Clin Microbiol (1993) 3.08
Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis (1999) 2.74
Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr (1980) 2.73
The clinical relevance of 'CSF viral culture'. A two-year experience with aseptic meningitis in Rochester, NY. JAMA (1982) 2.67
Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun (1986) 2.64
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect Immun (1987) 2.43
Penicillin-insensitive pneumococci. Case report and review. Am J Dis Child (1979) 2.25
Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol (2000) 2.16
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13
Prevalence of enterotoxigenicity in human and nonhuman isolates of Yersinia enterocolitica. Infect Immun (1978) 2.04
Experimental Yersinia enterocolitica enteritis in rabbits. Infect Immun (1980) 1.99
Ribavirin: adverse drug reactions, 1986 to 1988. Pediatr Infect Dis J (1990) 1.98
Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda) (1970) 1.97
Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr (1971) 1.75
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother (1982) 1.74
Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr (1985) 1.73
Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect Immun (1985) 1.72
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr (1981) 1.70
Clinical manifestations of coxsackievirus infections in children. Am J Dis Child (1974) 1.62
Invasiveness of Yersinia enterocolitica lacking the virulence plasmid: an in-vivo study. J Med Microbiol (1987) 1.62
In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097). Appl Microbiol (1971) 1.60
Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr (1988) 1.60
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. J Clin Invest (1982) 1.59
Pathogenic properties of Yersinia enterocolitica. Infect Immun (1980) 1.59
Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol. Antimicrob Agents Chemother (1975) 1.58
Biosynthesis of biotin in microorganisms. VI. Further evidence for desthiobiotin as a precursor in Eschericia coli. J Bacteriol (1967) 1.50
Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med (1970) 1.48
Vitamin A levels in children with measles in Long Beach, California. J Pediatr (1992) 1.42
In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum. Antimicrob Agents Chemother (1985) 1.42
Biosynthesis of biotin in microorganisms. IV. Repression and derepression of (+ -)-biotin synthesis from (+)-desthiobiotin. Arch Biochem Biophys (1966) 1.42
Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol (1984) 1.39
Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.37
Immunization today--a review. Can Med Assoc J (1973) 1.37
Adverse reactions to 1975 bivalent influenza vaccine in children. Can Med Assoc J (1977) 1.34
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? J Pediatr (1980) 1.34
Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3. Antimicrob Agents Chemother (1977) 1.34
Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr (1981) 1.33
The evaluation of racemic epinephrine in the treatment of infectious croup. Pediatrics (1973) 1.33
Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med (1984) 1.32
Improved method for collection of nasal mucus. J Infect Dis (1977) 1.31
Passive immunization in experimental Herpesvirus hominis infection of newborn mice. Infect Immun (1975) 1.31
Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrob Agents Chemother (1980) 1.30
The histopathology of rectosigmoid biopsies from adults with bloody diarrhea due to verotoxin-producing Escherichia coli. Am J Clin Pathol (1987) 1.29
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr (1986) 1.28
Meningococcal colonization and infection in children and their household contacts. Am J Epidemiol (1979) 1.27
The glomerulopathy of congenital syphilis--an immune deposit disease. J Pediatr (1972) 1.27
In vitro activity of BMY-28100 against common isolates from pediatric infections. Antimicrob Agents Chemother (1987) 1.26
A prospective search for congenital dermal abnormalities of the craniospinal axis. J Pediatr (1975) 1.23
Oral antibiotic therapy of skeletal infections in children. Pediatrics (1980) 1.23
The effect of dilution during culture on detection of low concentrations of bacteria in blood. Pediatr Infect Dis (1984) 1.22
Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr (1994) 1.21
Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection. Clin Pediatr (Phila) (1993) 1.21
Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. J Pediatr (1992) 1.20
Rapid identification of herpes simplex virus in tissue culture by direct immunofluorescence. J Lab Clin Med (1971) 1.19
Biosynthesis of desthiobiotin in cell-free extracts of Escherichia coli. J Bacteriol (1969) 1.19
Is Clostridium difficile pathogenic in infants? J Pediatr (1982) 1.19
Laboratory identification of Torulopsis glabrata: typical appearance on routine bacteriological media. Appl Microbiol (1970) 1.18
Exchange transfusion in the treatment of hepatic coma. J Pediatr (1969) 1.18
Risk factors for Escherichia coli O157:H7 infection in an urban community. J Infect Dis (1989) 1.18
Nosocomial infantile gastroenteritis associated with minirotavirus and calicivirus. J Pediatr (1978) 1.18
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother (1981) 1.17
Biosynthesis of biotin in microorganisms. V. Control of vitamer production. J Bacteriol (1967) 1.17
Single-dose pharmacokinetics of aztreonam in pediatric patients. Antimicrob Agents Chemother (1984) 1.16
Parainfluenza virus immunofluorescence. In vitro and clinical application of the direct method. Pediatrics (1971) 1.15
Demonstration of a capsule on Neisseria gonorrhoeae. N Engl J Med (1977) 1.14
Intradermal influenza immunization. Experience with Hong Kong vaccine. Am Rev Respir Dis (1971) 1.13
Management of the young febrile child. Commentary on practice guidelines. Pediatrics (1997) 1.13
Outpatient management of selected infants younger than two months of age evaluated for possible sepsis. Pediatr Infect Dis J (1990) 1.13
Parapneumonic pleural effusion and empyema in children. Review of a 19-year experience, 1962-1980. Clin Pediatr (Phila) (1983) 1.12
Prevalence of hepatitis C virus antibody among Korean adults. J Korean Med Sci (1992) 1.12
In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother (1985) 1.12
Enhancement of recovery of Neisseria meningitidis by gelatin in blood culture media. J Clin Microbiol (1981) 1.12
Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1986) 1.12
Rapid diagnosis of rotavirus gastroenteritis by a commercial latex agglutination test. J Clin Microbiol (1985) 1.12
Chromosomal location of mutations affecting the regualtion of biotin synthesis in Escherichia coli. Can J Microbiol (1975) 1.11
Torulopsis glabrata--an opportunistic pathogen in man. N Engl J Med (1970) 1.10
Mutant of Escherichia coli with derepressed levels of the biotin biosynthetic enzymes. J Bacteriol (1972) 1.10
In vitro sensitivity of Salmonella to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination. Antimicrob Agents Chemother (1973) 1.09
Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis. Antimicrob Agents Chemother (1982) 1.07
In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob Agents Chemother (1982) 1.07
Biosynthesis of biotin: synthesis of 7,8-diaminopelargonic acid in cell-free extracts of Escherichia coli. J Bacteriol (1971) 1.06
Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study. J Pediatr (1972) 1.05
Spread of multidrug-resistant Streptococcus pneumoniae in South Korea. Clin Infect Dis (1997) 1.05
Partial purification and properties of D-desthiobiotin synthetase from Escherichia coli. J Bacteriol (1970) 1.04